OIG Calls for Urgent “Skin Substitute” Payment Reform Based on Medicare Data
Summary: In a recent editorial, Dr. Caroline Fife reviews a new report from the Office of Inspector General (OIG) that reveals explosive growth and concerning patterns in Medicare payments for skin substitutes. Key findings include dramatic cost increases, widespread use in home settings, and possible misaligned incentives prompting overuse. The article calls for urgent reform to better align payment, usage, and quality.
Key Highlights:
- Medicare Part B spending on skin substitutes rose from roughly **$400 million** to nearly **$3 billion per quarter** between 2023 and 2024; total annual spending exceeded **$10 billion**, accounting for over 15% of all Part B drug costs.
- Home care cases (28% of patients) consumed over 50% of skin substitute spending—with average costs much higher than in clinics or physician offices.
- New providers (recently acquiring NPIs) reportedly bill nearly 100% of their skin substitute procedures without accompanying wound care management.
- The current payment structure (ASP-based) may incentivize overuse; procedures are being used for very minor wounds like scrapes or blisters at first visit, and claims patterns show potential for fraud or abuse.
Read the full article on CarolineFifeMD.com
Keywords:
skin substitute payment reform,
Medicare spending,
skin substitutes overuse,
Caroline Fife,
OIG report